Paragon 28 Gains FDA Clearance for Phantom ActivCore Nail

Paragon 28 received FDA 510(k) clearance to market the Phantom® ActivCore Nail, indicated for tibio-talo-calcaneal arthrodesis. Full commercial launch is slated for 2Q20, representing the second of three hindfoot fusion nailing systems that the company plans to introduce this year.

ActivCore features an outer spring sheath and inner...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us